What is the current size of the antipsychotic drugs market?

The antipsychotic drugs market generated USD 16.86 billion in 2024 and is expected to reach USD 24.61 billion by 2030. Read More

Which region is growing fastest?

Asia-Pacific is projected to expand at a 7.99% CAGR from 2025 to 2030, the highest regional growth rate in the industry. Read More

Why are long-acting injectable antipsychotics gaining traction?

LAIs cut 30-day readmissions from 8.3% to 1.9%, improve adherence, and deliver annual cost savings of more than USD 7,000 per patient, driving wider adoption among payers and clinicians. Read More

How will patent expiries affect market dynamics?

Loss of exclusivity for blockbuster atypicals such as Abilify Maintena and Invega Sustenna will heighten generic competition, trimming branded revenue and accelerating product bundling with digital supports. Read More

Which therapeutic application is set for the quickest growth?

Bipolar disorder treatment is forecast to post the fastest 8.01% CAGR, supported by expanded labels for newer agents like lumateperone. Read More

Antipsychotic Drugs Companies

This report lists the top Antipsychotic Drugs companies based on the 2023 & 2024 market share reports. Mordor Intelligence expert advisors conducted extensive research and identified these brands to be the leaders in the Antipsychotic Drugs industry.